Physician profile
Peter Martone
NPI 1881435923
$1,398.55
in general payments reported to CMS, 2019-2025
6 companies · $1,358 in 2025
The $1,358 reported for 2025 was more than what 93% of Orthodontics and Dentofacial Orthopedics providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $40.66 · 2025: $1,358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $608 · Travel and Lodging: $532 · Education: $250 · Gift: $8.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $607.57 |
| Travel and Lodging | $532.28 |
| Education | $250.00 |
| Gift | $8.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $1,251.37 | 2025 | Invisalign |
| Straumann USA LLC | $66.13 | 2025 | |
| Lightforce Orthodontics, INC. | $26.06 | 2024 | |
| World Class Technology Corporation | $23.18 | 2025 | Pitts21, Pitts21 Pro |
| USA Angelalign Technology Corp | $17.21 | 2025 | |
| Solventum Corporation | $14.60 | 2024 | Apc Flash-Free Victory Series Low Profile, Transbond Supreme Lv, Clarity Advanced |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Martone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.